Pharmafile Logo

Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today’s fast-paced digital environment.

- PMLiVE

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today’s fast-paced digital environment.

4. Stay Pithy and On Point
In an era where distractions abound, the key to maintaining focus in virtual meetings is brevity. We recommend frequent, brief touchpoints rather than prolonged sessions to keep participants engaged. This approach aligns with findings from medical education that favour micro-learning. Additionally, when crafting asynchronous interactions, consider breaking longer questions into smaller, manageable parts (e.g., parts a, b, c) to streamline understanding and prevent participant fatigue. Stick to no more than three sub-questions per main question to keep clarity and minimize confusion.

This tip is part of our series on enhancing the effectiveness of both asynchronous and synchronous virtual interactions.

Explore our blog for more in-depth strategies and insights on optimizing your virtual meetings: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Deepen your engagement with Impetus Digital:

Follow us for the latest updates and insights:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Using Technology to Improve Patient Experience

Dyan Bryson from Inspired Health Strategies discusses Patient Focused Drug Development, best practices for designing diverse and patient-centric trials, and how to use technology to improve the patient experience. She...

Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®

Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams.

Supporting Mental Health During a Global Pandemic

Sam Duboc, Chair & CEO of MindBeacon, explores virtual care and telehealth for treating depression, anxiety, addiction, and other conditions; mental health issues brought on by COVID-19; and how to...

Driving Digital Transformation in Healthcare Using AI

Tom Lawry, National Director for AI, Health & Life Sciences at Microsoft, shares how he helps life science companies implement innovative analytical solutions, the current barriers to enterprise-wide adoption of...

Blockchain in Healthcare: Predictions for the Post-COVID World

Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing. He will also share his expertise on digital health, innovation, connected...

AI-Driven Customer Journey Mapping in Biopharma

Philip Poulidis (CEO & Co-founder) and Orchid Jahanshahi (VP, Life Sciences) from ODAIA explores AI and big data for customer journey mapping and dynamic segmentation, data integration, omni-channel customer engagement,...

Virtual MSL training on the Impetus InSite Platform®: A Customer Story

How a client used our award-winning virtual engagement and learning tools to produce a series of online training modules.

Digital Health for Improving Care in Disadvantaged Populations

Peter Wood (Co-founder & COO) and Dr. Raj Padwal (Co-founder & CEO) from mmHg Inc. explain how their Sphygmo virtual care system can be used to monitor blood pressure, glucose,...

The Future of Digital Pills

Valerie Sullivan, President and CEO at etectRx, dives into digital pills in healthcare and clinical research. Among many other things, we discuss how Pharma companies can benefit from the ability...